Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | lysosomal alpha glucosidase | 0.019 | 0.6539 | 0.9092 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0042 | 0 | 0.5 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0042 | 0 | 0.5 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0042 | 0 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0042 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.7192 | 1 |
Echinococcus multilocularis | geminin | 0.0205 | 0.7192 | 1 |
Schistosoma mansoni | thyroid hormone receptor | 0.0158 | 0.515 | 0.7161 |
Schistosoma mansoni | alpha-glucosidase | 0.0163 | 0.5369 | 0.7464 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0048 | 0.0281 | 0.043 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0042 | 0 | 0.5 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0147 | 0.4629 | 0.6436 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.019 | 0.6539 | 0.9092 |
Loa Loa (eye worm) | hypothetical protein | 0.0048 | 0.0281 | 0.043 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0042 | 0 | 0.5 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0147 | 0.4629 | 0.6436 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0042 | 0 | 0.5 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0048 | 0.0281 | 0.043 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.7192 | 1 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0042 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0147 | 0.4629 | 0.6436 |
Trichomonas vaginalis | maltase-glucoamylase, putative | 0.0042 | 0 | 0.5 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.019 | 0.6539 | 0.9092 |
Trypanosoma brucei | glucosidase, putative | 0.0042 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0042 | 0 | 0.5 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0048 | 0.0281 | 0.043 |
Echinococcus granulosus | geminin | 0.0205 | 0.7192 | 1 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.019 | 0.6539 | 1 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0042 | 0 | 0.5 |
Schistosoma mansoni | alpha-glucosidase | 0.0163 | 0.5369 | 0.7464 |
Onchocerca volvulus | 0.011 | 0.2996 | 0.5 | |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0158 | 0.515 | 0.7161 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.019 | 0.6539 | 1 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0042 | 0 | 0.5 |
Schistosoma mansoni | thyroid hormone receptor | 0.0158 | 0.515 | 0.7161 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0042 | 0 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0042 | 0 | 0.5 |
Trichomonas vaginalis | sucrase-isomaltase, putative | 0.0042 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 6.3096 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.